Kintor Pharmaceutical Ltd KNTPF
$0.24
Last Updated: Aug 12, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Kintor Pharmaceutical Ltd. Stock Analysis KNTPF
United States Health Care Micro Cap Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 123 full-time employees. The company went IPO on 2020-05-22. The firm's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The firm has two core drugs in the dermatology field, KX-826 and GT20029. The firm's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Kintor Pharmaceutical Ltd (KNTPF) Chart
Financial Metrics & Statements of Kintor Pharmaceutical Ltd (KNTPF)
FAQ's for Kintor Pharmaceutical Ltd (KNTPF)
- As of August 2026, Kintor Pharmaceutical Ltd KNTPF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kintor Pharmaceutical Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kintor Pharmaceutical Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kintor Pharmaceutical Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kintor Pharmaceutical Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kintor Pharmaceutical Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Kintor Pharmaceutical Ltd (KNTPF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
